MMJ Recs

OCTOBER 9, 2023

Pain management in Texas has evolved significantly in recent years with the emergence of MMJ as a viable treatment option. As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

Cannabis Law Report

MARCH 1, 2022

We are looking for a legal compliance analyst/paralegal to join our team. The role would include being responsible for researching and analysing compliance policies and procedures, as well as developing and managing the compliance training programmes, and being responsible for legal administrative tasks.

Compliance 52

Compliance Compliance Legalization Research and Development 52

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

United Patients Group

OCTOBER 25, 2023

Navigating the complex world of medical marijuana can be challenging, particularly for individuals who are new to this alternative form of therapy. Patients using medical marijuana must familiarize themselves with their state’s specific regulations and guidelines to ensure they are in compliance with the law.

Marijuana 92

Marijuana Patients Research and Development Edibles 92

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

MMJ Recs

APRIL 25, 2024

However, the production of medical cannabis involves a meticulous process to ensure quality, potency, and safety for patients. Rigorous research and testing are conducted to assess the suitability of each strain for medical use, ensuring that patients receive optimal treatment outcomes.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

Cannabis Law Report

AUGUST 3, 2022

This tension in laws is also present in the issue of marijuana use by patients in hospital settings. The lack of robust research on cannabis products, cannabis as a therapy and dependence or addiction to cannabis heightens the challenge of developing sound policies on the use of cannabis in health care facilities.

Research and Development 98

Research and Development Policy Patients Compliance 98

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] More recently, MDMA therapy has inched closer to FDA approval. For the regulated community, this is a trend worth watching.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. from a 4-year college or university.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

JUNE 24, 2021

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. The shortages, exacerbated by a growing global demand for the products, led to a decision by the health directorate not to prescribe cannabis treatment to any new patients.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

NORML

FEBRUARY 22, 2019

Passage of this legislation is important because the Arizona Court of Appeals recently ruled that patients who rely on these products are not protected under the law and could face felony penalties for simply using their medicine. Click here to email your lawmakers in support of allowing patients to smoke medical cannabis. AZ resident?

Legislation 180

Legislation Hemp Compliance Compliance 180

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

MMJ Recs

FEBRUARY 21, 2024

Healthcare providers can offer guidance on potential benefits, risks, and interactions with existing treatments. Understanding the legal and regulatory landscape is essential to ensuring compliance and responsible use. First and foremost, establishing open communication with a healthcare provider is essential.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

MARCH 29, 2022

We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3%

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. from a 4-year college or university.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. Mr. Feldmann is a trusted advisor for marijuana businesses.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

AUGUST 17, 2021

Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Therapeutic Medical Devices are Preferred by Physicians and Patients for Acute and Chronic Respiratory Conditions. The Strategic Imperative.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JULY 24, 2021

Ahmad Doroudian, Chief Executive Officer of BetterLife, stated: “TD-010 is a potential novel therapy to treat debilitating anxiety disorders that show resistance to benzodiazepine and other therapies or require a long-term use and therefore put patients at risk for dependency. Benzodiazepine Dependency. neuroscience.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. from a 4-year college or university.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

AUGUST 19, 2021

The agreement allows medical cannabis flowers from Jamaica to be made available to German patients for the first time. Through the introduction of new cultivars, Cantourage and Cannim are providing new treatment options for patients in Europe.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio aims to be a revolutionary technology company for intranasal drug delivery in the treatment of CNS disorders. A potential solution is direct nose-to-brain delivery. About atai Life Sciences.

Research and Development 98

Research and Development Programs Treatment Media 98

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. NORML opposes this legislation. CT resident? CT resident?

Legislation 177

Legislation Decriminalization Patients Access 177

Cannabis Law Report

MAY 31, 2022

Two approaches apply to commercial operations—the traditional medical path and the emerging non-medical state-regulated path, while the other two paths are better seen as non-commercial—underground therapy and religious use. The first path, that of traditional medicine, currently offers patients limited options. Breakthrough Therapy.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

PrestoDoctor

AUGUST 2, 2023

It’s only legal to a limited extent and requires patients to have a medical cannabis card. In the state of Iowa, obtaining a medical cannabis card is a pathway towards accessing this alternative form of treatment legally and safely. The IDPH oversees the registration and regulation of patients, caregivers, and dispensaries.

Conditions 52

Conditions Epilepsy Dispensary Patients 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low. Product Split.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

OCTOBER 8, 2021

Cannabis Terapeutica reports… Sicily Region and medical cannabis: the mobilization of the Medical Cannabis Patients Committee . 30% -40% of newly diagnosed patients have difficulty controlling seizures. Normally, if a patient exhibits two or more seizures, he is initiated on antiepileptic drug (AED) treatment.

Epilepsy 52

Epilepsy Chronic Pain Patients Treatment 52

Cannabis Law Report

AUGUST 20, 2021

In an opinion piece published in The Times today , Conservative MP Dan Poulter, a practising NHS doctor, wrote that the drug has a lot of medical benefits – including the treatment of chronic pain, reduction of nausea for patients undergoing chemotherapy, and as a therapy for poor sleep and anxiety disorders.

Policy 105

Policy Chronic Pain Medicine Therapy 105

Cannabis Law Report

DECEMBER 9, 2021

“The FDA is supportive of our plans to develop regulated devices that would allow the use of novel analyses of multimodal data to capture, model, and map outputs that, if cleared, could be useful to clinicians and patients in the delivery of psychedelic and other perception-altering substances.” NEW YORK , Dec.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

The Cannigma

FEBRUARY 3, 2022

of babies, to doing robotic surgery, and now, helping geriatric patients navigate cannabis medicine. It is a challenging landscape to navigate and Dr. Bone is just doing phenomenal work helping patients. Bone has an impressive medical background from working as an OBGYN and delivering thousands (literally thousands!)

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. EG: Well, that was certainly her experience.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81